Clinical factors associated with initiation of and persistence with ADP receptor-inhibiting oral antiplatelet treatment after acute coronary syndrome: a nationwide cohort study from Finland

Juhani Airaksinen; P?l Hasvold; Ville Kyt?; Eeva Reissell; Anna Deleskog; Houssem Khanfir; Tuire Prami

首页> 外文期刊>BMJ Open >Clinical factors associated with initiation of and persistence with ADP receptor-inhibiting oral antiplatelet treatment after acute coronary syndrome: a nationwide cohort study from Finland

【24h】

Clinical factors associated with initiation of and persistence with ADP receptor-inhibiting oral antiplatelet treatment after acute coronary syndrome: a nationwide cohort study from Finland

机译：急性冠脉综合征后与ADP受体抑制性口服抗血小板治疗的开始和持续存在相关的临床因素：芬兰的一项全国队列研究

获取原文

掌桥外文数据库（机构版） >>

开具论文收录证明 >>

文献代查 >>

页面导航

摘要
著录项
相似文献
相关主题

摘要

Abstract Objectives To study patient selection for and persistence with ADP receptor-inhibiting oral antiplatelet (OAP) treatment after acute coronary syndrome (ACS). Design Observational, retrospective, cohort study linking real-life patient-level regist

机译：摘要目的研究急性冠脉综合征（ACS）后抑制ADP受体的口服抗血小板药物（OAP）治疗的患者选择和坚持性。设计观察性，回顾性，队列研究将现实生活中的患者水平注册人员联系起来

著录项

来源
《BMJ Open》 |2016年第11期|共页
作者
Juhani Airaksinen; P?l Hasvold; Ville Kyt?; Eeva Reissell; Anna Deleskog; Houssem Khanfir; Tuire Prami;
展开▼
作者单位

展开▼
收录信息
原文格式 PDF
正文语种
中图分类临床医学;
关键词

相似文献

外文文献
中文文献
专利

1. Initiation and persistence with dual antiplatelet therapy after acute myocardial infarction: a Danish nationwide population-based cohort study [J] . Gunnar H Gislason, P?l Hasvold, Anne Broe, BMJ Open . 2016,第5期

机译：急性心肌梗死后双重抗血小板治疗的启动和持续性：丹麦一项基于全国人群的队列研究
2. Initiation And Persistence With Antiplatelet Agents Among The Patients With Acute Coronary Syndromes: A Retrospective, Observational Database Study In China [J] . Xin Liu, Xiaoning He, Jing Wu, Patient Preference and Adherence . 2019,第3期

机译：急性冠状动脉综合征患者中抗血小板药物的启动和持续性：中国的回顾性，观察数据库研究
3. Ticagrelor: the evidence for its clinical potential as an oral antiplatelet treatment for the reduction of major adverse cardiac events in patients with acute coronary syndromes [J] . Bernardo Lombo, José G Díez Core Evidence . 2011,第4期

机译：替卡格雷（Ticagrelor）：作为口服抗血小板治疗可减少急性冠状动脉综合征患者主要不良心脏事件的临床潜力的证据
4. Antiplatelet Treatment in Acute Coronary Syndromes Where Do We Stand? [C] . M. Keltai International Congress on Coronary Artery Disease . 2007

机译：抗血小板治疗在急性冠状动脉综合征中我们站在哪里？
5. The Comparative Effectiveness, Safety, and Cost of Oral P2Y12 Antiplatelet Agents Following Acute Coronary Syndromes [D] . Belviso, Nicholas J. 2020

机译：口服P2Y12抗血小板药物的比较有效性，安全性和成本急性冠状动脉综合征
6. Clinical factors associated with initiation of and persistence with ADP receptor-inhibiting oral antiplatelet treatment after acute coronary syndrome: a nationwide cohort study from Finland [O] . Tuire Prami, Houssem Khanfir, Anna Deleskog, 2016

机译：急性冠脉综合征后与ADP受体抑制性口服抗血小板药物的启动和持续存在相关的临床因素：芬兰的一项全国队列研究
7. Clinical factors associated with initiation of and persistence with ADP receptor-inhibiting oral antiplatelet treatment after acute coronary syndrome: a nationwide cohort study from Finland [O] . Prami, Tuire, Khanfir, Houssem, Deleskog, Anna, 2017

机译：急性冠状动脉综合征中aDp受体抑制口服抗血小板治疗引发和持续存在的临床因素：来自芬兰的全国性队列研究

Clinical factors associated with initiation of and persistence with ADP receptor-inhibiting oral antiplatelet treatment after acute coronary syndrome: a nationwide cohort study from Finland

摘要

著录项

相似文献

相关主题

期刊订阅